10. Fearon ER, Pardoll DM, Itaya T, Golumbek P, Levitsky HI, Simons JW, Karasuyama H, 
Vogelstein B, Frost P. Interleukin-2 production by tumor cells bypasses T helper function in the 
generation of an anti-tumor response. Cell 60:387-403, 1990. 
11. Gansbacher B, Zier K, Daniels B, Caronin K, Banneiji R, Gilboa E. Interleukin-2 gene 
transfer into tumor cells abrogates tumorigenicity and induces protective immunity. J Exp Med 172: 
1217-1223, 1990. 
12. Watanabe Y, Kuribayashi K, Miyatake S, Nishihara K, Nakayama EL, Taniyama T, Sakata 
TA. Exogenous expression of mouse interferon gamma cDNA in mouse neuroblastoma C1300 cells 
results in reduced tumorigenicity by augmented anti-tumor immunity. Proc. Natl Acad Sci 86:9456- 
9460, 1989. 
13. Tepper RI, Pattengale PK, Leder P. Murine interleukin-4 displays potent anti-tumor activity 
in vivo. Cell 57:503-512, 1989. 
14. Hoover HC, Brandhorst JS, Peters LC et al., Adjuvant active specific immunotherapy for 
human colorectal cancer: 6.5-year median follow-up of a phase III prospectively randomized trial. J 
Clin Oncol 11:390-399, 1993. 
15. Rosenberg SA, Aebersold P, Cornetta K, et al. Gene transfer into humans - immunotherapy 
of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene 
transduction. N Eng J Med 323:570-578, 1990. 
16. Miller AD, and Rosman GJ. Improved retroviral vectors for gene transfer and expression. 
BioTechniques 7:980, 1989. 
Recombinant DNA Research, Volume 18 
[645] 
